For several years, courts have wrestled with the question of whether subjective clinical decisions regarding the type and amount of treatment patients may need can be false for purposes of establishing False Claims Act (FCA) liability.  The question of whether the FCA requires a showing of objective falsity has divided appellate courts in a number of recent high-profile cases.

For their part, practitioners have kept a close eye on whether the Supreme Court might bring much-needed clarity to this issue.  On February 22, the Supreme Court declined to do so, denying a petition for certiorari with respect to the Third Circuit’s opinion in U.S. ex rel. Druding v. Care Alternatives.

In Druding, the relators, who were former employees of a hospice provider, filed a qui tam action alleging that the hospice provider submitted false claims by routinely certifying patients who were not terminally ill for hospice care.  During the litigation, the relators’ expert examined the medical records of nearly 50 patients and concluded that the documentation did not support a certification of terminal illness for approximately 35% of those patients.  The hospice provider produced its own expert who testified a physician could have reasonably concluded that the patients at issue were terminally ill and needed hospice care.

Continue Reading Supreme Court Declines to Weigh in on Key Falsity Question

We released our Healthcare Fraud & Abuse Annual Review earlier this month. To serve as a companion to the Review, we’re hosting a complimentary webinar on Thursday, February 18, 2021 from 8:00-10:00 a.m. PT / 10:00 a.m.-12:00 p.m. CT / 11:00 a.m.-1:00 p.m. ET. that will take a deeper dive into key focus areas covered throughout the Review, including:

  •  Enforcement update and issues to watch.
  • False Claims Act update.
  • Stark Law/Anti-Kickback Statute enforcement updates.
  • Managed care and pharma/medical device developments.

We hope you can join us for this timely discussion of healthcare fraud issues from the past year and how they will impact proceedings in 2021. If you have not done so already, please click to download your copy of the current edition of the Healthcare Fraud & Abuse Annual Review.

Who Should Attend?

  • In-house legal counsel
  • Compliance officers
  • Privacy officers
  • C-level executives, consultants and principals

Accreditation

Tennessee CLE
This program is pending approval for two hours General Tennessee CLE credit. Please provide your BPR number upon registration in order for Bass, Berry & Sims to report your participation to the Tennessee CLE Commission following the conference.

Other State CLE
Bass, Berry & Sims does not seek direct accreditation from states outside of Tennessee, but some states allow attorneys to earn credit through reciprocity or self-submission. Certificates of completion and other common supporting documents will be provided for use in jurisdictions outside of Tennessee.

Questions?

Submit your questions for presenters upon registration or email questions to Claire Krummenacher.

Bass, Berry & Sims is pleased to announce the release of the newest edition of its Healthcare Fraud & Abuse Annual Review examining important healthcare fraud developments in 2020. Compiled by the firm’s Healthcare Fraud Task Force, the Review provides an in-depth and comprehensive analysis of the past year’s court decisions involving the False Claims Act, settlements involving significant fraud and abuse issues, and enforcement developments affecting the healthcare industry.

When we released last year’s Healthcare Fraud & Abuse Review in early 2020, none of us could have predicted what the year ahead would bring. By March 2020, we saw healthcare professionals standing at the forefront of one of the greatest health crises in a generation and we saw our healthcare system quickly stressed to the breaking point by the COVID-19 pandemic. Over the next several months, we saw trillions of stimulus dollars distributed by the federal government to provide economic relief to individuals and businesses. By 2020’s end, we saw the beginnings of a massive and historic vaccine rollout designed to stem the continued rising tide of COVID-19 infections against the backdrop of leadership changes at the highest levels of government.

Along the way, we continued to pay close attention to the fraud and abuse issues facing the healthcare industry. Our Healthcare Fraud & Abuse Review covers these issues and looks ahead to the challenges likely to come for healthcare providers facing the prospect of increased government scrutiny, whistleblower lawsuits under the False Claims Act, and government regulators pursuing civil and criminal healthcare fraud enforcement.

This year’s Healthcare Fraud & Abuse Review examines:

  • Issues for the healthcare industry to watch in 2021.
  • Enforcement implications of the Coronavirus Aid, Relief, and Economic Security (CARES) Act /COVID-19 relief.
  • Noteworthy False Claims Act settlements from 2020.
  • Comprehensive coverage of significant False Claims Act decisions.
  • Notable developments involving the Stark Law and Anti-Kickback Statute.

Enforcement developments impacting the pharmaceutical and medical device industries.

Learn More at the Healthcare Fraud & Abuse Annual Review Webinar

As a companion to this year’s Review, the firm will host a webinar on Thursday, February 18 from 11:00 a.m. – 1:00 p.m. ET / 10:00 a.m. – 12:00 p.m. CT / 8:00 – 10:00 a.m. PT. The webinar will take a deeper dive into key focus areas covered throughout the Review, including:

  • Enforcement updates and issues to watch.
  • False Claims Act updates.
  • Stark Law/Anti-Kickback Statute enforcement updates.
  • Managed care and pharma/medical device developments.

The webinar is complimentary and pending approval for two hours General Tennessee CLE credit. Please provide your BPR number upon registration in order for Bass, Berry & Sims to report your participation to the Tennessee CLE Commission following the webinar.

Bass, Berry & Sims does not seek direct accreditation from states outside of Tennessee, but some states allow attorneys to earn credit through reciprocity or self-submission. Certificates of completion and other common supporting documents will be provided for use in jurisdictions outside of Tennessee.

Questions? Please email Claire Krummenacher.

One of the first indicators that may tip off a healthcare provider or government contractor that their organization may be the subject of a False Claims Act (FCA) investigation is contact with a government investigator.  That contact may take many forms – service of a subpoena or Civil Investigative Demand (CID), an interview of an employee, or simply a phone call by a government regulator or investigator.  How an organization responds to those earliest contacts often sets the tone for how the government investigation unfolds.

Organizations with well-developed policies and procedures addressing how the organization will respond to contacts by government regulators often have a more orderly process to guide the organization in responding to government investigations (referred to herein as a Government Response Policy).  A Government Response Policy can set a clear tone of cooperation by the organization with any appropriately authorized government inquiry, while at the same time making clear that the organization will assert all protections afforded by law in any such investigation or inquiry.  And, a well-crafted Government Response Policy also can make clear to employees that concealment, alteration or destruction of information or the making of false or misleading statements to regulators will not be tolerated.

An effective Government Response Policy depends upon educating employees regarding the types of contacts that an organization or an employee may receive from government regulators and on establishing clear points of contact and lines of communication within the organization.  Typically, the organization will establish its legal department as a central point of contact for government inquiries or investigations (and organizations without a legal department would have to think through an alternative appropriate point of contact) as the entity within the organization best suited to coordinate the organization’s response either directly or through outside counsel.  Below we provide broad principles and guidelines that should be considered in preparing an organization’s Government Response Policy.

This post contains five parts and looks at the following:

  • Responding to a subpoena or CID.
  • Responding to visits by investigators at an office/facility.
  • Responding to a search warrant.
  • Responding to an interview request.
  • Responding to inbound calls from government officials.

Continue Reading An Ounce of Prevention: Effective Corporate Policies for Dealing with Government Investigations and Inquires

Improper billing for electro-acupuncture using a “P-Stim” device (or peri-auricular stimulation device) has been the subject of two False Claims Act (FCA) settlements already in 2021, following a trend of such enforcement actions within the past year.

Each of the recent settlements, detailed further below, involve providers billing federal healthcare programs for acupuncture using P-Stim devices under HCPCS Code L8649.  Unlike P-Stim devices, though, which are attached to the ears of a patient using needles and adhesives without surgery or anesthesia, HCPCS Code L8649 applies to a product that is surgically implanted into a patient using anesthesia. Medicare, TRICARE and the Federal Employees Health Benefit Program (FEHBP) do not reimburse for acupuncture devices like P-Stim, nor do they reimburse for P-Stim as a neurostimulator or an implantation of neurostimulator electrodes.  In addition to P-Stim, the brand names for these devices include ANSiStim, E-pulse, Stivax and NeuroStim.

Notably, none of these enforcement actions originated from qui tam whistleblowers but rather were the product of affirmative government investigations by the U.S. Department of Justice, U.S. Attorneys’ Offices, the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), and CMS’s Center for Program Integrity. These settlements—coming from different jurisdictions and concerning different types of providers and practices—demonstrate the government’s ongoing, nationwide effort to investigate the improper billing of electro-acupuncture devices:

Continue Reading Improper Billing of “P-Stim” Devices is Focus of Recent FCA Settlements

As 2020 draws to a close, we take a look back at a number of the most significant False Claims Act (FCA) cases of the prior 12 months.  Although no blockbuster cases emerged, such as the Supreme Court’s 2016 decision in Escobar, there were a number of noteworthy cases that will have lasting impact on future FCA litigation.  We discuss those cases briefly below.  We expect to cover these cases and much more in our Healthcare Fraud and Abuse Review, which we will release in early 2021.

Materiality

U.S. ex rel. Janssen v. Lawrence Memorial Hospital, 949 F.3d 533 (10th Cir. 2020)

Background.  In 2016, the Supreme Court held in Escobar that whether a defendant can be held liable under the FCA for violating a statute, rule, regulation, or contract provision turns, in part, on the elements of materiality and scienter, which the Court said are “rigorous” and “demanding.”  Post-Escobar, courts have grappled with specific applications of these standards, with some courts appearing to apply them less “rigorously” than others.

Allegations.  In U.S. ex rel. Janssen v. Lawrence Memorial Hospital, the relator primarily alleged that the defendant hospital falsified patient arrival times associated with certain CMS pay-for-reporting and pay-for-performance programs.  The relator introduced proof that the hospital had knowingly falsified arrival times in patient records by recording actual arrival times on patient triage sheets but then entering later times in the medical record or delaying patient registration until after the administration of some tests.

Continue Reading Key False Claims Act Cases in 2020

Bass, Berry & Sims and the Tennessee Hospital Association hosted the Sixth Annual Nashville Healthcare Fraud Conference on December 2 and 3. Though typically an in-person event, this year’s conference moved to a virtual platform. That move allowed for the addition of Day 1 primer sessions covering the basics of the False Claims Act, principles of an effective compliance program, how to deal with whistleblowers, and recent significant settlements under the Stark Law and the Anti-Kickback Statute. The Day 2 sessions covered advanced topics ranging from a healthcare fraud and abuse year-in-review, the impact of the global pandemic on fraud enforcement from the perspective of healthcare providers and government officials, criminal healthcare fraud enforcement developments, and how to address compliance issues during a pandemic.

“Each year, we strive to put together content that we believe will greatly benefit members of the healthcare industry in gaining a deeper understanding of the fraud and abuse issues confronting them,” said Brian Roark, chair of the Bass, Berry & Sims Healthcare Fraud Task Force. “There is no question that most healthcare providers are dealing with these types of issues daily, and the conference provides a forum to explore how providers, government regulators and outside counsel view these issues.”

This year, more than 600 attendees participated in the conference from over 40 states and the District of Columbia. In addition to members of the Bass, Berry & Sims Healthcare Fraud Task Force, panelists participating in the conference included in-house attorneys and compliance professionals from Humana, Sanford Health, RWJBarnabas Health Systems, Methodist LeBonheur Healthcare, Saber Healthcare, Tenet Healthcare, Henry Ford Health System, naviHEALTH and Virtua Health, as well as several government attorneys from both the state and federal level.

Continue Reading Sixth Annual Healthcare Fraud Conference Highlights Key Risk Areas and Enforcement Developments for Healthcare Providers

Access RecordingIt is safe to say that 2020 has been nothing short of challenging for the healthcare industry, especially when it comes to maintaining data privacy and security. Among countless other areas, the impact of COVID-19 has resulted in a spike in telehealth options, creating more vulnerabilities for the security of patient data. More than ever, healthcare professionals must prioritize data security and proactively assess areas of risk within their company’s operational structure.

In this webinar available now on demand, Bass, Berry & Sims attorneys are joined by professionals in the healthcare field to discuss best practices, new enforcement updates, and COVID-19-related developments to help protect your company’s data, maintain compliance with government agencies, and respond accordingly if and when a breach occurs.

This complimentary webinar covers the following topics:

  • The Basics – Beginner HIPAA knowledge for those new to this area of work, including helpful resources and best practices.
  • Enforcement Actions – Government agency developments and updates on the current regulatory climate.
  • Pandemic Pitfalls – Impacts resulting from COVID-19 and how to spot bad actors taking advantage of vulnerabilities.

Who Should Attend?

  • In-house legal counsel.
  • Privacy officers.
  • Compliance officers.
  • C-level executives, consultants and principals in the healthcare industry.

CLE Credit

This program has been approved for General Tennessee CLE credit. Certificate of completion and other necessary application forms provided for use in other jurisdictions.

Please join us for the 6th Annual Nashville Healthcare Fraud Conference hosted by Bass, Berry & Sims and the Tennessee Hospital Association. Because we are unable to provide an in-person forum due to ongoing concerns resulting from the COVID-19 pandemic, we are converting the conference to a virtual platform.

We are excited about this year’s complimentary CLE program, which will provide the same caliber of practical advice, insight into significant fraud and abuse issues facing healthcare professionals, and thoughtful discussion from industry panelists for which this conference is known.

Additionally, for the first time, we are expanding the conference to two days with the first day focused on providing a primer, covering healthcare fraud and abuse matters for attorneys newer to the industry or practice. Topics will include conducting effective internal investigations and an overview of the False Claims Act.

The second day will follow our traditional format of providing practical tips and takeaways regarding healthcare fraud enforcement, including:

  • Our annual review of the most important healthcare fraud issues from the prior year.
  • Effective management of healthcare investigations during the COVID-19 pandemic.
  • How the COVID-19 pandemic has impacted the government’s perspective on healthcare fraud matters.
  • Implications and potential risk exposure stemming from CARES Act funding.

Click here to view the current agenda.

At the conclusion of the conference on December 3, we will be offering breakout sessions to further the dialogue on subject matters important to you. Please be on the lookout for communications regarding breakout session details.

Continue Reading [REGISTER NOW] Healthcare Fraud Conference | December 2-3, 2020